Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1636205

This article is part of the Research TopicIntegrating Approaches Traditional and Biomedical Therapies in Rheumatological and other Inflammatory Musculoskeletal DiseasesView all 4 articles

New progress in animal models for studying hyperuricemia

Provisionally accepted
Senyue  ZhangSenyue ZhangKai Qing  LiKai Qing LiHu  ZhangHu ZhangTong  FuTong FuYanchun  MaYanchun MaShuxiang  ZhangShuxiang ZhangGuoli  XingGuoli XingYing  TongYing Tong*
  • Heilongjiang University of Chinese Medicine, Harbin, China

The final, formatted version of the article will be published soon.

Hyperuricemia (HUA) is a prevalent metabolic disorder driven by dysregulated purine metabolism and impaired urate excretion, and robust animal models are critical for elucidating its pathophysiology and guiding therapy development. This review systematically examines chemically induced, gene-edited, environmental, exercise and microbiota-based HUA models across rodents, poultry, primates, zebrafish and silkworms, highlighting each model's strengths and limitations in mimicking human uric acid handling. We discuss how these models have validated standard urate-lowering treatments-such as xanthine oxidase inhibitors and uricosurics-and uncovered emerging therapeutic targets, including the gut-NLRP3 inflammasome axis and SIRT1-mediated ABCG2 regulation. Finally, we propose a unified three-tier framework encompassing biochemical, mechanistic and pathological criteria to standardize model evaluation and accelerate translational research in hyperuricemia.

Keywords: Hyperuricemia, Animal Models, Modeling method, gene editing, Evaluation indicators

Received: 27 May 2025; Accepted: 11 Aug 2025.

Copyright: © 2025 Zhang, Li, Zhang, Fu, Ma, Zhang, Xing and Tong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ying Tong, Heilongjiang University of Chinese Medicine, Harbin, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.